header image

[Sign Up Now] to Receive Our FREE Daily SCVTV-SCVNews Digest by E-Mail

Inside
Weather


 
Calendar
Today in
S.C.V. History
March 18
1919 - Fire destroys abandoned second Southern Hotel, built 1878 in Newhall (corner Main & Market) [story]
Second Southern Hotel


In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases (NIAID) launched a clinical trial Friday to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.

“Although ZMapp has been used to treat several Ebola-infected patients in recent months, we cannot determine if the drug actually benefitted those patients because it was not administered within the context of a clinical trial,” said Anthony S. Fauci, M.D., director of the NIAID, at the National Institutes of Health (NIH). “This clinical trial will help us determine if ZMapp and other treatments are safe and effective for use in the current devastating outbreak in West Africa as well as in future outbreaks.”

Ebola virus buds from the surface of a Vero cell from the African green-monkey kidney epithelial cell line. Photo: National Institute of Allergy and Infectious Diseases.

Ebola virus buds from the surface of a Vero cell from the African green-monkey kidney epithelial cell line. Photo: National Institute of Allergy and Infectious Diseases.

ZMapp, developed by Mapp Biopharmaceutical Inc., based in San Diego, is composed of three different proteins called monoclonal antibodies. ZMapp is designed to prevent the progression of Ebola virus disease within the body by targeting the main surface protein of the Ebola virus. The antibodies comprising ZMapp are produced in tobacco plants specially bioengineered to produce large quantities of these proteins. Studies in nonhuman primates demonstrated that ZMapp has strong antiviral activity and rescued the animals from death as late as five days after infection with Zaire ebolavirus. The drug has not yet been tested in human clinical trials, but was administered under emergency use authorization to nine infected patients in Africa, the United States, and Western Europe.

The trial will be led by co-principal investigators Richard T. Davey, Jr., M.D., deputy clinical director of NIAID’s Division of Intramural Research, and Moses Massaquoi, M.D., National Chair for Case Management at the Ebola Incident Management System in Monrovia.  The trial will enroll adults and children of any age who have been admitted to Ebola treatment units in Liberia, health care workers who were infected with Ebola virus in West Africa and have returned to the United States for treatment, and adults and children who may have acquired Ebola infection in the United States through secondary transmission. All participants will provide informed consent prior to enrollment. Treatment centers in Monrovia, Liberia, will include the ELWA 2 Ebola treatment unit and the Monrovia Medical Unit—staffed by the Commissioned Corps of the U.S. Public Health Service. The NIH Clinical Center in Bethesda, Maryland will serve as a treatment center in the U.S. Additional trial sites under consideration in the U.S. include the Walter Reed National Military Medical Center in Bethesda, Maryland, Emory University Hospital in Atlanta, and the University of Nebraska Medical Center in Omaha, Nebraska.

All participants will receive the optimized standard of care for treating Ebola infection, which includes providing intravenous fluids, balancing electrolytes, maintaining oxygen status and blood pressure and treating other infections if they occur. Participants will then be assigned randomly to one of two groups: the first group, which will act as the control, will continue to receive the current optimized standard of care. The second group will receive the optimized standard of care plus three separate intravenous infusions of ZMapp administered three days apart. The total dose of ZMapp at each infusion will depend on the weight of the participant. Study participants will be monitored up to 30 days following discharge from the hospital and may return for outpatient visits for additional follow up.

Researchers designed the study protocol to include a series of two-arm comparisons (the first being ZMapp compared to the current standard of care) to establish a framework to evaluate multiple potential Ebola treatments in the future. If one investigational treatment proves to be statistically more effective, it will then become the basis of the new standard of care against which additional investigational Ebola interventions could be tested and compared. Each experimental therapy will be examined in up to 100 participants per arm. If scientists are unable to establish a significant difference after enrolling 100 participants per arm, then that particular treatment will be declared ineffective and scientists will begin testing the next therapy. These additional treatments may also include the following:

* Tekmira siRNA from Tekmira Pharmaceuticals Corp., based in Burnaby, British Columbia

* Favipiravir from Toyama Chemical Co. LTD, based in Tokyo, Japan

* Convalescent or post-immunization plasma collected from recent Ebola infection survivors. It is possible that this category could potentially be expanded to include plasma donors who have participated in Phase 1 Ebola vaccine clinical trials and whose plasma shows high neutralizing activity against the virus.

* BCX4430 from BioCryst, based in Durham, North Carolina

* AVI-7537 from Sarepta, based in Cambridge, Massachusetts

NIH is collaborating with experts from the University of Minnesota; Leidos Biomedical Research Inc.; Emory University Hospital; the University of Nebraska Medical Center; the Centers for Disease Control and Prevention; the U.S. Food and Drug Administration; the Uniformed Services University of the Health Sciences; and the Walter Reed National Military Medical Center to conduct this trial. The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, is funding the production of ZMapp. The trial is expected to conclude in December 2016. Given the current decline in the number of new Ebola cases in Liberia, study investigators anticipate the need for flexibility in the conduct and design of the trial to address the changing nature of the outbreak in West Africa. Consideration will also be given to other sites in the outbreak region that express interest.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Comment On This Story
COMMENT POLICY: We welcome comments from individuals and businesses. All comments are moderated. Comments are subject to rejection if they are vulgar, combative, or in poor taste.
REAL NAMES ONLY: All posters must use their real individual or business name. This applies equally to Twitter account holders who use a nickname.

No Comments

    Leave a Comment


    SCV NewsBreak
    Current Time 0:00
    /
    Duration Time 0:00
    Loaded: 0%
    0:00
    Progress: 0%
    Stream TypeLIVE
    Remaining Time -0:00
     
    1x
    LOCAL NEWS HEADLINES
    Monday, Mar 17, 2025
    June 21: Santa Clarita Dodger Day Returns
    The city of Santa Clarita invites residents to purchase tickets for the 46th Annual city of Santa Clarita Dodger Day.
    Monday, Mar 17, 2025
    Schiavo Advances Public, Victim, Small Business Safety Legislation
    Assemblywoman Pilar Schiavo, D-Chatsworth, has introduced a legislation package which includes the Victim and Witness Protection Act (AB 535), Small Business Retail Theft Grants (AB 949), Police Pension Tax Exemption (AB 814) and protecting funding for crime victims (VOCA Funding Act) in the state budget.
    Monday, Mar 17, 2025
    March 17-22: Eight Productions Filming in SCV
    The city of Santa Clarita Film Office has released the list of eight productions filming in the Santa Clarita Valley for the week of Monday, March 17 to Saturday, March 22.
    Keep Up With Our Facebook

    Latest Additions to SCVNews.com
    1919 - Fire destroys abandoned second Southern Hotel, built 1878 in Newhall (corner Main & Market) [story]
    Second Southern Hotel
    The regular meeting of the William S. Hart Union High School District Governing Board of Trustees will be held Wednesday, March 19, beginning with a closed session at 6:15 p.m., followed by an open session at 7 p.m.
    March 19: Hart Board Considers Appointment of Fiscal Services Director
    Join the Santa Clarita Valley Chamber of Commerce for a Grand Opening Ribbon Cutting at Beyond Harmony Medical Spa & Luxury Aesthetics, Wednesday, March 26 at 4 p.m.
    March 26: Beyond Harmony Grand Opening Ribbon Cutting
    The city of Santa Clarita invites residents to purchase tickets for the 46th Annual city of Santa Clarita Dodger Day.
    June 21: Santa Clarita Dodger Day Returns
    The Small Business Development Center and city of Santa Clarita will host two Enhancing Your Digital Footprint series webinars, noon-1 p.m. Wednesdays, March 19 and 26.
    March 19, 26: Enhancing Your Digital Footprint Series
    Assemblywoman Pilar Schiavo, D-Chatsworth, has introduced a legislation package which includes the Victim and Witness Protection Act (AB 535), Small Business Retail Theft Grants (AB 949), Police Pension Tax Exemption (AB 814) and protecting funding for crime victims (VOCA Funding Act) in the state budget.
    Schiavo Advances Public, Victim, Small Business Safety Legislation
    On Wednesday, April 2 6-8:30 p.m., Serata Italiana, the renowned Italian language and culture club, will host an exclusive event at Total Wine & More featuring real estate expert Natalie Blancardi and a virtual introduction to Italian attorney Antonello Pierro.
    April 2: Total Wine & More Hosts Serata Italiana Event
    The city of Santa Clarita Film Office has released the list of eight productions filming in the Santa Clarita Valley for the week of Monday, March 17 to Saturday, March 22.
    March 17-22: Eight Productions Filming in SCV
    The track teams of The Master's University maintained their strong start to the 2025 outdoor season at the Ross and Sharon Irwin Classic on Saturday. March 15 in San Diego. Five standards were added and 11 top-10 marks in school history were achieved.
    Mustangs’ Track Teams Crush Point Loma Meet
    The Master's University men's basketball team's season ended Saturday night, March 15 as the Southern Oregon Raiders defeated the Mustangs 76-71 in The MacArthur Center.
    Season Ends for TMU Men’s Hoops
    Old Town Newhall has earned its title as Santa Clarita’s Premier Arts and Entertainment District and has also become well-known as a hub for prime dining and shopping.
    Ken Striplin | Stimulating the SENSES in Old Town Newhall
    The Master's University women's basketball team's season came to an end with its first round loss in the NAIA Women's Basketball National Championship Tournament on Saturday, March 15.
    Season Ends in Oklahoma for Lady Mustangs
    Braden Van Groningen collected 24 kills as The Master's University men's volleyball team came back to defeat the OUAZ Spirit 23-25, 25-17, 25-18, 25-13 Saturday afternoon, March 15 in The MacArthur Center.
    Mustangs Get to 4-0 With Four-Set Win Over OUAZ
    1927 - Newhall telephone exchange, est. 1900, now serves 100 phones [story]
    telephone
    2003 - Lifesize sculpture honoring heroes of St. Francis Dam disaster unveiled in Santa Paula [video]
    The Warning
    1942 - Emery Whilton's Florafaunium opens in Lebec [story]
    Florafaunium
    Today in SCV History (March 15)
    After the January wildfires, the county began a review to assess our evacuation policies and emergency alert systems. The state has also commissioned a review of our preparedness efforts, immediate response to the fires and the recovery time frame of the incident.
    Kathryn Barger | Wildfire Analysis
    Island Pacific Santa Clarita is gearing up for a celebration of National Lumpia Day with a lumpia-eating contest on Saturday, March 15, from 3-6:30 p.m.
    March 15: Lumpia Eating Contest at Island Pacific Santa Clarita
    The regular meeting of the Saugus Union School District Governing Board of Trustees will be held Tuesday, March 18 beginning at 6:30 p.m.
    March 18: Saugus School Board to Receive Measure EE Annual Report
    After a successful pilot program in the Saugus Union School District, School Day Café has expanded the use of a new, eco-friendly serving tray option across all Santa Clarita Valley elementary schools.
    SCV Elementary School Lunches Offered on Eco-friendly Serving Trays
    In support of “Making Water Conservation a California Way of Life,” the Santa Clarita Valley Water Agency is developing a Water Use Efficiency Strategic Plan to establish a comprehensive water conservation strategy.
    March 26: SCV Water Hosts Public Workshop on Water Use Efficiency Plan
    College of the Canyons Women's Tennis got back in the win column with an 8-1 conference road win at Glendale College.
    Canyons Gets Back in the Win Column 8-1 at Glendale
    The Michael Hoefflin Foundation for Children’s Cancer invites the community to join the annual "Walk 4 MHF Help Kids Fight Cancer" to help raise awareness and support local families affected by childhood cancer.
    April 5: Annual Walk 4 MHF Help Kids Fight Cancer at Central Park
    The Santa Clarita Valley Historical Society has announced that the St. Francis Dam Tour scheduled for Saturday, March 15 has been postponed until Saturday, April 26.
    March 15: St. Francis Dam Tour Postponed Due to Rain
    SCVNews.com